Genetics

This blog post examines how genetic variation may influence the prognosis of multiple sclerosis, a disease marked by highly variable clinical outcomes. While MS susceptibility genetics is now well established, the genetic determinants of disease course remain less clearly defined. The post discusses evidence linking genetic factors to age at onset, relapse activity, disability progression, cognitive impairment, MRI findings, and cerebrospinal fluid biomarkers. It also highlights the current limitations of prognostic genetics, including small effect sizes, inconsistent replication, heterogeneous study designs, and treatment-related confounding. Overall, the article argues that genetic markers are not yet ready for routine clinical prognostic use but may become valuable within integrated precision-medicine models that combine genomic, clinical, imaging, and biomarker data.